Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody-Reference-Cited by-同舟云学术

Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody

Published:2017-11 Issue:11 Volume:28 Page:2893-2895
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Tomita Y.,Sueta D.,Kakiuchi Y.,Saeki S.,Saruwatari K.,Sakata S.,Jodai T.,Migiyama Y.,Akaike K.,Hirosako S.,Fujisue K.,Yamamura S.,Miyazaki S.,Takashio S.,Izumiya Y.,Nakamura K.,Tsujita K.,Ichiyasu H.,Fujii K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/11/2893/21556032/mdx326.pdf

Reference7 articles.

1. Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis;Foks;Br J Pharmacol,2017

2. Fulminant myocarditis with combination immune checkpoint blockade;Johnson;N Engl J Med,2016

3. Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy;Naidoo;J Clin Oncol,2017

4. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies;Naidoo;Ann Oncol,2015

5. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes;Freeman-Keller;Clin Cancer Res,2016

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitor-associated cardiovascular toxicities: A review;Heliyon;2024-03

2. Pathogenesis, Diagnosis and Treatment of Immune-Related Cardiotoxicity;Advances in Clinical Medicine;2024

3. A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors;European Journal of Medical Research;2023-11-08

4. Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma;Frontiers in Oncology;2023-07-24

5. An Increased Understanding of the Association Between Atherosclerosis and Immune Checkpoint Inhibitors;Current Cardiology Reports;2023-07-03